MYC and cancer: On the other hand, cancer cells with deregulated growth signaling pathways driven by oncogenic drivers, such as Ras, which leads to deregulated c-Myc expression, often are unable to downregulate c-Myc, nor exit from the cell cycle, nor switch off the anabolic pathways.